NCT03670069 2024-05-08Itacitinib in Treating Patients With Refractory Metastatic/Advanced SarcomasFred Hutchinson Cancer CenterPhase 1 Terminated27 enrolled
NCT04099277 2021-08-31A Study of LY3435151 in Participants With Solid TumorsEli Lilly and CompanyPhase 1 Terminated2 enrolled 8 charts